Ye Congyan, Ma Xueping, Shi Bo, Yan Rui, Fu Shizhe, Wang Kairu, Yan Ru, Jia Shaobin, Yang Shengping, Cong Guangzhi
Institute of Medical Sciences, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Institute of Cardiovascular Medicine, General Hospital of Ningxia Medical University, Ningxia, China.
BMC Cardiovasc Disord. 2024 Dec 19;24(1):706. doi: 10.1186/s12872-024-04303-1.
Acute kidney injury (AKI) complicates transcatheter aortic valve replacement (TAVR), leading to higher mortality. The incidence and effects of AKI on clinical outcomes in patients undergoing TAVR without chronic kidney disease (CKD) are unclear. We aimed to determine the association between AKI and in-hospital outcomes in patients with TAVR using propensity score matching (PSM).
Using International Classification of Diseases-10th Revision codes, we queried the National Inpatient Sample for TAVR performed between 2016 and 2021. Patients were divided into two groups according to perioperative AKI development. Patients with CKD or on permanent hemodialysis at baseline were excluded. We conducted 1:1 PSM to assemble a cohort of patients with similar baseline characteristics. Multivariate logistic regression was used to assess the association between AKI and in-hospital outcomes. Sensitivity analysis was conducted to evaluate the robustness of our inferences.
Of 47,372 unweighted patient admissions for TAVR, 1617 (3.41%) had a concomitant diagnosis of AKI. The incidence of AKI decreased from 4.82 to 3.18% from 2016 to 2021 (P-trend < 0.01). Before PSM, patients with AKI had a significantly higher rate of in-hospital mortality compared with those without AKI (6.12% vs. 0.48%, respectively; odds ratio [OR] 8.59, 95% confidence interval [CI] 6.32-11.68). Using the PSM algorithm, 1579 well-matched patients were included in each group. After PSM, an association was observed between patients with TAVR and concomitant AKI and a higher risk of in-hospital mortality (6.21% vs. 1.08%, respectively; OR 5.96; 95% CI 3.54-10.04). In subgroup analyses stratified according to age (≤ 80 and > 80 years), sex (male/female), and hypertension status, consistent associations were observed between AKI and the risk of in-hospital mortality. AKI patients were at higher risk for acute myocardial infarction (OR 1.78, 95% CI 1.35-2.34), major bleeding (OR 1.62, 95% CI 1.13-2.33), blood transfusion (OR 1.65, 95% CI 1.28-2.11), and cardiogenic shock (OR 3.73, 95% CI 2.77-5.01). No significant betweengroup differences were observed in stroke (P = 0.12).
AKI was a strong predictor of in-hospital mortality in patients undergoing TAVR without CKD and was associated with higher post-procedure complication rates.
急性肾损伤(AKI)使经导管主动脉瓣置换术(TAVR)变得复杂,导致更高的死亡率。AKI在无慢性肾脏病(CKD)的TAVR患者中的发生率及其对临床结局的影响尚不清楚。我们旨在使用倾向评分匹配(PSM)确定AKI与TAVR患者住院结局之间的关联。
我们使用国际疾病分类第十版编码,查询了2016年至2021年间进行TAVR的全国住院患者样本。根据围手术期AKI的发生情况将患者分为两组。排除基线时患有CKD或接受永久性血液透析的患者。我们进行了1:1的PSM以组建一组具有相似基线特征的患者。使用多变量逻辑回归评估AKI与住院结局之间的关联。进行敏感性分析以评估我们推论的稳健性。
在47372例未加权的TAVR患者入院病例中,1617例(3.41%)同时诊断为AKI。AKI的发生率从2016年的4.82%降至2021年的3.18%(P趋势<0.01)。在PSM之前,与无AKI的患者相比,有AKI的患者住院死亡率显著更高(分别为6.12%和0.48%;比值比[OR]8.59,95%置信区间[CI]6.32 - 11.68)。使用PSM算法,每组纳入1579例匹配良好的患者。PSM后观察到,TAVR患者合并AKI与更高的住院死亡风险相关(分别为6.21%和1.08%;OR 5.96;95%CI 3.54 - 10.04)。在根据年龄(≤80岁和>80岁)、性别(男性/女性)和高血压状态分层的亚组分析中,观察到AKI与住院死亡风险之间存在一致的关联。AKI患者发生急性心肌梗死(OR 1.78,95%CI 1.35 - 2.34)、大出血(OR 1.62,95%CI 1.13 - 2.33)、输血(OR 1.65,95%CI 1.28 - 2.11)和心源性休克(OR 3.73,95%CI 2.77 - 5.)的风险更高。在卒中方面未观察到显著的组间差异(P = 0.12)。
AKI是无CKD的TAVR患者住院死亡的有力预测指标,并且与术后更高的并发症发生率相关。